Inventor · disambiguated record
Steven Idell
Also filed as: IDELL STEVEN
11 granted patents·10 pending applications·71 citations·filing 2002–2024
89Inventor score
Top patents by PatentIndex Score
21 records- 0197US11780879B2Inhibition of pulmonary fibrosis with nutlin-3A and peptidesUNIV TEXAS·Filed 2021·Granted Oct 10, 2023·7 cites·19 claims
- 0295US11161875B2Inhibition of pulmonary fibrosis with nutlin-3a and peptidesUNIV TEXAS·Filed 2019·Granted Nov 2, 2021·8 cites·16 claims
- 0395US9630990B2Inhibition of pulmonary fibrosis with nutlin-3A and peptidesUNIV TEXAS·Filed 2014·Granted Apr 25, 2017·33 cites·15 claims
- 0494US12173089B2Inhibition of pulmonary fibrosis with nutlin-3A and peptidesUNIV TEXAS·Filed 2023·Granted Dec 24, 2024·1 cites·18 claims
- 0590US10377796B2Inhibition of pulmonary fibrosis with nutlin-3a and peptidesUNIV TEXAS·Filed 2017·Granted Aug 13, 2019·7 cites·17 claims
- 0689US2025304619A1Inhibition of pulmonary fibrosis with nutlin-3a and peptidesUNIV TEXAS·Filed 2024·Application pending·0 cites
- 0784US8697840B2Peptide inhibition of lung epithelial apoptosis and pulmonary fibrosisSHETTY SREERAMA·Filed 2009·Granted Apr 15, 2014·12 cites·14 claims
- 0883US2023100467A1Inhibition of pulmonary fibrosis with nutlin-3a and peptidesUNIV TEXAS·Filed 2022·Application pending·0 cites
- 0970US11033611B2Compositions and methods for administration of an enzyme to a subject's airwayUNIV TEXAS·Filed 2019·Granted Jun 15, 2021·0 cites·15 claims
- 1068US2021330741A1Polypeptide therapeutics and uses thereofUNIV TEXAS·Filed 2021·Application pending·0 cites
- 1163US2018086791A1Inhibition of pulmonary fibrosis with nutlin-3a and peptidesUNIV TEXAS·Filed 2017·Application pending·0 cites
- 1260US7332469B2Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesionsUNIV TEXAS·Filed 2003·Granted Feb 19, 2008·3 cites·6 claims
- 1359US2020164028A1Polypeptide therapeutics and uses thereofUNIV TEXAS·Filed 2019·Application pending·0 cites
- 1454US2016279209A1Compositions and methods for administration of an enzyme to a subject's airwayUNIV TEXAS·Filed 2014·Application pending·0 cites
- 1549US2018050084A1Polypeptide therapeutics and uses thereofUNIV TEXAS·Filed 2016·Application pending·0 cites
- 1645US12083098B2Treatment of idiopathic pulmonary fibrosis with glycogen synthase kinase 3 form β inhibitorsACTUATE THERAPEUTICS INC·Filed 2019·Granted Sep 10, 2024·0 cites·8 claims
- 1745US2005048045A1Regulation of urokinase receptor expression by phosphoglycerate kinaseUNIV TEXAS·Filed 2004·Application pending·0 cites
- 1841US9808505B2Suppression of malignant mesothelioma by overexpression or stimulation of endothelial protein C receptors (EPCR)UNIV TEXAS·Filed 2014·Granted Nov 7, 2017·0 cites·3 claims
- 1940US2018140547A1Compositions and methods for administration of an enzyme to a subject's airwayUNIV TEXAS·Filed 2016·Application pending·0 cites
- 2037US2004033200A1Modified FVII in treatment of ARDSFiled 2002·Application pending·0 cites
- 2136US10175255B2Fibrinolytic potential: a test of pleural fluid to predict outcomes and guide dosing in fibrinolytic therapyUNIV TEXAS·Filed 2016·Granted Jan 8, 2019·0 cites·34 claims
Join the waitlist — get patent alerts
Get an alert when Steven Idell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →